<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">World J Surg Oncol</journal-id>
      <journal-id journal-id-type="iso-abbrev">World J Surg Oncol</journal-id>
      <journal-title-group>
        <journal-title>World Journal of Surgical Oncology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1477-7819</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25382741</article-id>
      <article-id pub-id-type="pmc">4289362</article-id>
      <article-id pub-id-type="publisher-id">1863</article-id>
      <article-id pub-id-type="doi">10.1186/1477-7819-12-335</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Breast cancer arising within fibroadenoma: collective analysis of case reports in the literature and hints on treatment policy</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Wu</surname>
            <given-names>Yu-Ting</given-names>
          </name>
          <address>
            <email>taichung1031@hotmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
          <xref ref-type="aff" rid="Aff6"/>
          <xref ref-type="aff" rid="Aff7"/>
          <xref ref-type="aff" rid="Aff8"/>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Chen</surname>
            <given-names>Shou-Tung</given-names>
          </name>
          <address>
            <email>1886@cch.org.tw</email>
          </address>
          <xref ref-type="aff" rid="Aff6"/>
          <xref ref-type="aff" rid="Aff7"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Chih-Jung</given-names>
          </name>
          <address>
            <email>132540@cch.org.tw</email>
          </address>
          <xref ref-type="aff" rid="Aff9"/>
          <xref ref-type="aff" rid="Aff10"/>
          <xref ref-type="aff" rid="Aff11"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kuo</surname>
            <given-names>Yao-Lung</given-names>
          </name>
          <address>
            <email>ylkuo@mail.ncku.edu.tw</email>
          </address>
          <xref ref-type="aff" rid="Aff12"/>
          <xref ref-type="aff" rid="Aff13"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tseng</surname>
            <given-names>Ling-Ming</given-names>
          </name>
          <address>
            <email>lmtseng@vghtpe.gov.tw</email>
          </address>
          <xref ref-type="aff" rid="Aff14"/>
          <xref ref-type="aff" rid="Aff15"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Dar-Ren</given-names>
          </name>
          <address>
            <email>115045@cch.org.tw</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
          <xref ref-type="aff" rid="Aff6"/>
          <xref ref-type="aff" rid="Aff7"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kuo</surname>
            <given-names>Shou-Jen</given-names>
          </name>
          <address>
            <email>40225@cch.org.tw</email>
          </address>
          <xref ref-type="aff" rid="Aff6"/>
          <xref ref-type="aff" rid="Aff7"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Lai</surname>
            <given-names>Hung-Wen</given-names>
          </name>
          <address>
            <email>143809@cch.org.tw</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
          <xref ref-type="aff" rid="Aff6"/>
          <xref ref-type="aff" rid="Aff7"/>
          <xref ref-type="aff" rid="Aff15"/>
        </contrib>
        <aff id="Aff5"><label/>Endoscopic and Oncoplastic Breast Surgery Center, Comprehensive Breast Cancer Center, Changhua Christian Hospital, 135 Nanhsiao Street, Changhua City, Changhua County 500 Taiwan </aff>
        <aff id="Aff6"><label/>Division of General Surgery, Changhua Christian Hospital, 135 Nanhsiao Street, Changhua City, Changhua County 500 Taiwan </aff>
        <aff id="Aff7"><label/>Department of Surgery, Comprehensive Breast Cancer Center, Changhua Christian Hospital, 135 Nanhsiao Street, Changhua City, Changhua County 500 Taiwan </aff>
        <aff id="Aff8"><label/>Department of Surgery, Sinying Hospital, Ministry of Health and Welfare, 73 Xinyi Street, Xinying Dist, Tainan City, 730 Taiwan </aff>
        <aff id="Aff9"><label/>Department of Surgical Pathology, Changhua Christian Hospital, 135 Nanhsiao Street, Changhua City, Changhua County 500 Taiwan </aff>
        <aff id="Aff10"><label/>School of Medicine, Chung Shan Medical University, Taichung, No. 110, Sec. 1, Jianguo N. Rd, Taichung City, 40201 Taiwan </aff>
        <aff id="Aff11"><label/>Department of Medical Technology, Jen-Teh Junior College of Medicine, Nursing and Management, No 79-9, Sha-Luen Hu, Xi-Zhou Li, Hou-Loung Town, Miaoli County, Taiwan </aff>
        <aff id="Aff12"><label/>Division of General Surgery, Department of Surgery, National Cheng-Kung University Hospital, Tainan and Dou-Liou branches, No.138, Sheng Li Road, Tainan 704, Taiwan and No.345, Zhuangjing Rd, Douliu City, Yunlin County 64043 Taiwan </aff>
        <aff id="Aff13"><label/>Division of Plastic and Reconstructive Surgery, Department of Surgery, National Cheng-Kung University Hospital, Tainan and Dou-Liou branches, No.138, Sheng Li Road, Tainan 704, Taiwan and No.345, Zhuangjing Rd, Douliu City, Yunlin County 64043 Taiwan </aff>
        <aff id="Aff14"><label/>Division of General Surgery, Department of Surgery, Taipei Veterans General Hospital, No.201, Sec. 2, Shipai Rd., Beitou District, Taipei City, 11217 Taiwan </aff>
        <aff id="Aff15"><label/>School of Medicine, National Yang Ming University, Taipei, No.155, Sec.2, Linong Street, Taipei, 112 Taiwan </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>10</day>
        <month>11</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <volume>12</volume>
      <elocation-id>335</elocation-id>
      <history>
        <date date-type="received">
          <day>3</day>
          <month>4</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>9</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Wu et al.; licensee BioMed Central Ltd. 2014</copyright-statement>
        <license license-type="open-access">
          <license-p>This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Breast cancer arising within a fibroadenoma (BcaFad) is rare; the rate varies from 0.002% to 0.125% in fibroadenoma specimens. Owing to its rarity, the clinicopathologic feature and treatment principle of BcaFad is still not clear. Therefore, the aim of this study was to perform a collective analysis of case reports in the literature to identify the characteristics and optimal treatment for BcaFad.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>We analyzed an aggregated sample of 30 patients with BcaFad from case reports in the literature (<italic>n</italic> =24 cases) and our present study (<italic>n</italic> =6 cases). We collected and analyzed the clinicopathologic features and prognoses of patients with BcaFad, as well as treatments they received.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>The patients&#x2019; mean age at diagnosis was 46.9&#xA0;years. Twenty BcaFad patients (66.7%) received breast-conserving surgery (BCS), and nine other patients (30.0%) were treated with mastectomy. The rate of lymph node metastasis in BcaFad patients was 23.8%. The breakdown of the histological types of BcaFad was invasive ductal carcinoma (53.3%), followed by ductal carcinoma <italic>in situ</italic> (23.3%), lobular carcinoma <italic>in situ</italic> (16.7%) and invasive lobular carcinoma (13.3%). More than half of patients with positive hormone receptor status received hormone therapy. Most BcaFad patients with lymph node metastases received chemotherapy, and 20.0% of BcaFad patients treated with BCS received further radiotherapy. Only one patient had recurrence after surgery, and another had lung metastasis when diagnosed with BcaFad.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Most BcaFad patients could be managed by BCS. Adjuvant radiotherapy could be performed, but was not mandatory. Chemotherapy should be considered as a treatment option in the presence of lymph node metastasis.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Breast cancer</kwd>
        <kwd>Fibroadenoma</kwd>
        <kwd>Hormone therapy</kwd>
        <kwd>Radiotherapy</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2014</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Fibroadenoma is the most common cause of discrete breast lumps in young females
[<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>] and occurs in 25% of asymptomatic women. Benign, asymptomatic fibroadenomas usually can be managed with nonoperative follow-up
[<xref ref-type="bibr" rid="CR3">3</xref>&#x2013;<xref ref-type="bibr" rid="CR5">5</xref>]. Symptomatic, progressively enlarging masses or atypical presentations, however, may warrant surgical excision.</p>
      <p>Although very rare, breast cancer arising within fibroadenoma (BcaFad) can still be found. The incidence of BcaFad ranges from 0.125% to 0.02%, according to different reports
[<xref ref-type="bibr" rid="CR6">6</xref>&#x2013;<xref ref-type="bibr" rid="CR8">8</xref>]. In such circumstances, carcinomas <italic>in situ</italic> (66.9% lobular carcinoma <italic>in situ</italic> (LCIS) and 12.4% ductal carcinoma <italic>in situ</italic> (DCIS)) are found to be more common than invasive carcinomas (11% invasive ductal carcinoma (IDC) and 3.4% invasive lobular carcinoma (ILC))
[<xref ref-type="bibr" rid="CR9">9</xref>]. The optimal management of patients with BcaFad is still not clear. Little information is available in current breast cancer management consensus guidelines
[<xref ref-type="bibr" rid="CR10">10</xref>&#x2013;<xref ref-type="bibr" rid="CR13">13</xref>]. It is unknown whether such patients should be treated similarly to those with breast cancer.</p>
      <p>Owing to the rarity of BcaFad cases, clinicians in individual medical institutions have very little experience in treating these patients. Therefore, a collective case study is needed for more information about the optimal management of BcaFad. In this article, we present our experience with six BcaFad cases and used a systematic literature review process to find some characteristics of and hints for the optimal care of these patients.</p>
    </sec>
    <sec id="Sec2" sec-type="methods">
      <title>Methods</title>
      <p>To further elucidate the characteristics and optimal management of patients with BcaFad, we performed a collective analysis of case reports in the literature and our six cases. The literature review was performed through PubMed searches to collect English-language articles about BcaFad published between January 1986 and January 2013. The keywords used in the search use were "fibroadenoma", "carcinoma", "breast", "ductal" and "lobular".</p>
      <p>The literature search was limited to studies focused on BcaFad with descriptions of diagnosis and/or treatment. The investigated parameters included age, gender, tumor size, diagnostic image, operation method, histology, hormone receptor status (including estrogen receptor (ER) and progesterone receptor (PR)), Human epidermal growth factor receptor 2 (HER2) status, chemotherapy and radiation therapy. The searches were limited to human studies. Articles were excluded if they did not present BcaFad, patient information or treatment details. Articles published in any language other than English were also excluded.</p>
      <p>Demographic data collected and analyzed included age, gender, size of the primary lesion, duration of follow-up, image findings, fine-needle aspiration cytology or core-needle biopsy results, pathology, operation method, postoperative therapy and recurrence or metastasis of the tumor.</p>
    </sec>
    <sec id="Sec3" sec-type="results">
      <title>Results</title>
      <p>In our literature review, we collected 24 cases with detailed information from 21 English-language articles. After combining these with our 6 cases, the study population comprised 30 BcaFad patients (Figure&#xA0;
<xref rid="Fig1" ref-type="fig">1</xref> and Table&#xA0;
<xref rid="Tab1" ref-type="table">1</xref>). All of the patients were female, and their mean age at diagnosis was 46.9&#xA0;years old (range, 27 to 80&#xA0;years old). The mean duration from the finding of fibroadenoma to surgical excision was 61.2&#xA0;months (range, 0.5 to 600&#xA0;months). The mean tumor size of the fibroadenoma was 2.46&#xA0;cm (range, 0.8 to 5.1&#xA0;cm). Most of the cancers found inside the breast fibroadenoma were <italic>in situ</italic> carcinoma or early breast cancer with minimal or small tumor size. The distribution of tumor locations was the right side (53.3%), followed by the left side (40.0%) and bilateral breast (3.3%). The clinicopathologic data of these 30 patients are summarized in Table&#xA0;
<xref rid="Tab1" ref-type="table">1</xref>.<fig id="Fig1"><label>Figure 1</label><caption><p>
<bold>Flowchart of the search strategy.</bold> We initially identified 861 articles in the databases searched according to the keywords used. We excluded 801 articles after title screening because they did not mention fibroadenoma-related carcinoma, leaving 60 articles retrieved that described a significant relationship between fibroadenoma and carcinoma. We excluded 22 articles for lack of case details, even in the abstracts; 5 articles for no case data in the main text; 3 articles for focusing on other rare cancers linked to fibroadenoma; and 9 articles because they were case analyses or reviews. Thus, 24 cases from 21 studies were included, together with our 6 cases, which gave us a total of 30 cases for the final analysis.</p></caption><graphic xlink:href="12957_2014_1863_Fig1_HTML" id="d30e556"/></fig></p>
      <table-wrap id="Tab1">
        <label>Table 1</label>
        <caption>
          <p>
<bold>Demographic data from identified studies in the literature and our cases</bold>
<sup><bold>a</bold></sup>
</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th>Patient</th>
              <th>Study</th>
              <th>Age (yr)</th>
              <th>Tumor size (cm)</th>
              <th>Noted tumor duration (months)</th>
              <th>Histology</th>
              <th>TNM stage</th>
              <th>Surgery</th>
              <th>LN dissection</th>
              <th>LN metastasis</th>
              <th>Receptor status</th>
              <th>C/T</th>
              <th>H/T</th>
              <th>R/T</th>
              <th>Outcome</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td>1</td>
              <td>Kurosumi <italic>et al</italic>., 1994
[<xref ref-type="bibr" rid="CR14">14</xref>]</td>
              <td>42</td>
              <td>2 &#xD7; 3</td>
              <td>21</td>
              <td>IDC</td>
              <td/>
              <td>Ex</td>
              <td>A</td>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>2</td>
              <td>Sarela <italic>et al</italic>., 1995
[<xref ref-type="bibr" rid="CR15">15</xref>]</td>
              <td>56</td>
              <td>2 &#xD7; 3</td>
              <td>2</td>
              <td>LCIS + IDC</td>
              <td/>
              <td>MT</td>
              <td>A</td>
              <td>P</td>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>3</td>
              <td>Shah <italic>et al</italic>., 1999
[<xref ref-type="bibr" rid="CR16">16</xref>]</td>
              <td>45</td>
              <td>2.5 &#xD7; 2</td>
              <td>3</td>
              <td>LCIS</td>
              <td>TisN0M0</td>
              <td>Ex</td>
              <td/>
              <td>N</td>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>4</td>
              <td>Yano <italic>et al</italic>., 2001
[<xref ref-type="bibr" rid="CR17">17</xref>]</td>
              <td>54</td>
              <td>2</td>
              <td/>
              <td>ILC</td>
              <td>TisN0M0</td>
              <td>Ex</td>
              <td>A</td>
              <td>N</td>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>5</td>
              <td>Kuijper <italic>et al</italic>., 2002
[<xref ref-type="bibr" rid="CR18">18</xref>]</td>
              <td>46</td>
              <td>Multiple</td>
              <td/>
              <td>DCIS + LCIS</td>
              <td>TisN0M0</td>
              <td>MT</td>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>6</td>
              <td>Abe <italic>et al</italic>., 2004
[<xref ref-type="bibr" rid="CR19">19</xref>]</td>
              <td>42</td>
              <td>5.1 &#xD7; 4.4</td>
              <td>60</td>
              <td>IDC</td>
              <td/>
              <td>MT</td>
              <td>A</td>
              <td>P</td>
              <td>ER-PR+</td>
              <td>Yes</td>
              <td>Yes</td>
              <td>No</td>
              <td/>
            </tr>
            <tr>
              <td>7</td>
              <td>Stafyla <italic>et al</italic>., 2004
[<xref ref-type="bibr" rid="CR20">20</xref>]</td>
              <td>27</td>
              <td>3.4</td>
              <td/>
              <td>LCIS</td>
              <td>TisN0M0</td>
              <td>Ex</td>
              <td/>
              <td>N</td>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>8</td>
              <td>Shin <italic>et al</italic>., 2006
[<xref ref-type="bibr" rid="CR21">21</xref>]</td>
              <td>51</td>
              <td>1.5 &#xD7; 1</td>
              <td>12</td>
              <td>IDC</td>
              <td/>
              <td>MT</td>
              <td>S</td>
              <td>N</td>
              <td>ER+PR+</td>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>9</td>
              <td>Yuen <italic>et al</italic>., 2007
[<xref ref-type="bibr" rid="CR22">22</xref>]</td>
              <td>39</td>
              <td>1.1</td>
              <td/>
              <td>ILC</td>
              <td/>
              <td>BCS</td>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>10</td>
              <td>Yuen <italic>et al</italic>., 2007
[<xref ref-type="bibr" rid="CR22">22</xref>]</td>
              <td>45</td>
              <td>0.8</td>
              <td/>
              <td>ILC</td>
              <td/>
              <td>BCS</td>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>11</td>
              <td>Borecky and Rickard, 2008
[<xref ref-type="bibr" rid="CR23">23</xref>]</td>
              <td>64</td>
              <td>1.2</td>
              <td/>
              <td>IDC</td>
              <td>T1bN0M0</td>
              <td>BCS</td>
              <td>S</td>
              <td>N</td>
              <td>ER+PR+</td>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>12</td>
              <td>Borecky and Rickard, 2008
[<xref ref-type="bibr" rid="CR23">23</xref>]</td>
              <td>80</td>
              <td>4.5</td>
              <td>600</td>
              <td>IDC</td>
              <td/>
              <td>BCS</td>
              <td>S</td>
              <td>N</td>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>13</td>
              <td>Borecky and Rickard, 2008
[<xref ref-type="bibr" rid="CR23">23</xref>]</td>
              <td>53</td>
              <td>1.7</td>
              <td>12</td>
              <td>DCIS</td>
              <td>TisN0M0</td>
              <td>Ex</td>
              <td>S</td>
              <td>N</td>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>14</td>
              <td>Gashi-Luci <italic>et al</italic>., 2009
[<xref ref-type="bibr" rid="CR24">24</xref>]</td>
              <td>39</td>
              <td>2.6 &#xD7; 1.6</td>
              <td/>
              <td>IDC</td>
              <td/>
              <td>MT</td>
              <td>A</td>
              <td>N</td>
              <td>ER-PR-</td>
              <td/>
              <td/>
              <td/>
              <td>R</td>
            </tr>
            <tr>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td>HER2-</td>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>15</td>
              <td>Khandelwal <italic>et al</italic>., 2009
[<xref ref-type="bibr" rid="CR25">25</xref>]</td>
              <td>35</td>
              <td>2 &#xD7; 3</td>
              <td>2</td>
              <td>IDC</td>
              <td/>
              <td>BCS</td>
              <td>A</td>
              <td>P</td>
              <td>ER+PR+</td>
              <td>Yes</td>
              <td>Yes</td>
              <td>Yes</td>
              <td/>
            </tr>
            <tr>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td>HER2-</td>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>16</td>
              <td>Iyengar <italic>et al</italic>., 2009
[<xref ref-type="bibr" rid="CR26">26</xref>]</td>
              <td>43</td>
              <td>1.8</td>
              <td>24</td>
              <td>IDC</td>
              <td/>
              <td>MT</td>
              <td/>
              <td/>
              <td>ER-PR-</td>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td>HER2+</td>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>17</td>
              <td>Rao <italic>et al</italic>., 2010
[<xref ref-type="bibr" rid="CR27">27</xref>]</td>
              <td>30</td>
              <td>4 &#xD7; 2</td>
              <td>1</td>
              <td>IDC</td>
              <td/>
              <td>MT</td>
              <td>A</td>
              <td>P</td>
              <td>ER-PR-</td>
              <td>Yes</td>
              <td>No</td>
              <td>Yes</td>
              <td/>
            </tr>
            <tr>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td>HER2-</td>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>18</td>
              <td>Petersson <italic>et al</italic>., 2010
[<xref ref-type="bibr" rid="CR28">28</xref>]</td>
              <td>49</td>
              <td>3</td>
              <td>48</td>
              <td>IDC</td>
              <td/>
              <td>Ex</td>
              <td>S</td>
              <td>N</td>
              <td>ER+PR+</td>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td>HER2-</td>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>19</td>
              <td>Kato <italic>et al</italic>., 2011
[<xref ref-type="bibr" rid="CR29">29</xref>]</td>
              <td>42</td>
              <td>1.5</td>
              <td/>
              <td>DCIS</td>
              <td>TisN0M0</td>
              <td>BCS</td>
              <td>S</td>
              <td>N</td>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>20</td>
              <td>Ooe <italic>et al</italic>., 2011
[<xref ref-type="bibr" rid="CR30">30</xref>]</td>
              <td>46</td>
              <td>2.4 &#xD7; 1.7</td>
              <td>60</td>
              <td>DCIS</td>
              <td>TisN0M0</td>
              <td>BCS</td>
              <td>S</td>
              <td>N</td>
              <td>ER+PR+</td>
              <td>No</td>
              <td>Yes</td>
              <td>Yes</td>
              <td/>
            </tr>
            <tr>
              <td>21</td>
              <td>Tajima <italic>et al</italic>., 2011
[<xref ref-type="bibr" rid="CR31">31</xref>]</td>
              <td>60</td>
              <td>1.9 &#xD7; 1.6</td>
              <td>3</td>
              <td>ILC</td>
              <td/>
              <td>BCS</td>
              <td/>
              <td/>
              <td>ER+PR+</td>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td>HER2-</td>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>22</td>
              <td>Abu-Rahmeh <italic>et al</italic>., 2012
[<xref ref-type="bibr" rid="CR32">32</xref>]</td>
              <td>69</td>
              <td>5</td>
              <td>180</td>
              <td>IDC</td>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td>Lung metastasis<sup>b</sup>
</td>
            </tr>
            <tr>
              <td>23</td>
              <td>Jahan <italic>et al</italic>., 2012
[<xref ref-type="bibr" rid="CR33">33</xref>]</td>
              <td>55</td>
              <td>5 &#xD7; 4 &#xD7; 3</td>
              <td>240</td>
              <td>IDC</td>
              <td/>
              <td>MT</td>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>24</td>
              <td>Butler <italic>et al</italic>., 2012
[<xref ref-type="bibr" rid="CR34">34</xref>]</td>
              <td>46</td>
              <td>0.8 &#xD7; 0.8</td>
              <td/>
              <td>ILC</td>
              <td>T1bN0M0</td>
              <td>Ex</td>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>25</td>
              <td>Present study</td>
              <td>39</td>
              <td>2.7 &#xD7; 2.7</td>
              <td>24</td>
              <td>IDC</td>
              <td>T1aN0M0</td>
              <td>BCS</td>
              <td>S</td>
              <td>N</td>
              <td>ER+PR+</td>
              <td>No</td>
              <td>Nr</td>
              <td>Nr</td>
              <td/>
            </tr>
            <tr>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td>HER2-</td>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>26</td>
              <td>Present study</td>
              <td>31</td>
              <td>3.5 &#xD7; 3.4</td>
              <td>84</td>
              <td>IDC</td>
              <td>T1aN1M0</td>
              <td>MT</td>
              <td>A</td>
              <td>P</td>
              <td>ER+PR+</td>
              <td>Yes</td>
              <td>Yes</td>
              <td>No</td>
              <td/>
            </tr>
            <tr>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td>HER2-</td>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>27</td>
              <td>Present study</td>
              <td>30</td>
              <td>1.5 &#xD7; 1.4</td>
              <td/>
              <td>DCIS</td>
              <td>TisN0M0</td>
              <td>BCS</td>
              <td/>
              <td/>
              <td>ER+PR+</td>
              <td>No</td>
              <td>Yes</td>
              <td>No</td>
              <td/>
            </tr>
            <tr>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td>HER2-</td>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>28</td>
              <td>Present study</td>
              <td>63</td>
              <td>1.2</td>
              <td>0.5</td>
              <td>DCIS</td>
              <td>TisN0M0</td>
              <td>BCS</td>
              <td>S</td>
              <td>N</td>
              <td>ER+PR+</td>
              <td>No</td>
              <td>Yes</td>
              <td>Yes</td>
              <td/>
            </tr>
            <tr>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td/>
              <td>HER2-</td>
              <td/>
              <td/>
              <td/>
              <td/>
            </tr>
            <tr>
              <td>29</td>
              <td>Present study</td>
              <td>48</td>
              <td>0.9</td>
              <td>3</td>
              <td>DCIS</td>
              <td>TisN0M0</td>
              <td>Ex</td>
              <td>S</td>
              <td>N</td>
              <td/>
              <td>No</td>
              <td>No</td>
              <td>No</td>
              <td/>
            </tr>
            <tr>
              <td>30</td>
              <td>Present study</td>
              <td>40</td>
              <td>0.6</td>
              <td>0</td>
              <td>IDC</td>
              <td>T1bN0M0</td>
              <td>MT</td>
              <td>S</td>
              <td>N</td>
              <td>ER +PR-</td>
              <td>No</td>
              <td>Yes</td>
              <td>No</td>
              <td/>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>
<sup>a</sup>A, Axillary lymph node dissection level I/II/III; B, Benign; C/T, Chemotherapy; ER, Estrogen receptor; Ex, Excision; HER2, Human epidermal growth factor receptor 2 ; H/T, Hormone therapy; LN, Lymph node; M, Malignancy; MT, Mastectomy; N, Negative; Nr, Patient refuse; P, Positive; PR, Progesterone receptor; R, Recurrence; R/T, Radiotherapy; S, Sentinel lymph node dissection; TNM, Tumor, node, metastasis. <sup>b</sup>Lung metastasis at diagnosis.</p>
        </table-wrap-foot>
      </table-wrap>
      <p>Twenty (66.7%) of thirty patients with BcaFad received breast-conserving surgery (BCS), and nine other patients (30.0%) received mastectomies. One (patient 26) of these nine mastectomy patients received immediate breast reconstruction (Figure&#xA0;
<xref rid="Fig2" ref-type="fig">2</xref>). Furthermore, five (23.8%) of twenty-one patients with the diagnosis of lymph node status had lymph node metastasis. Most patients were diagnosed with IDC (16 cases, 53.3%), followed by DCIS (7 cases, 23.3%), LCIS (5 cases, 16.7%) and ILC (4 cases, 13.3%) (Table&#xA0;
<xref rid="Tab2" ref-type="table">2</xref>). Among these patients, only one patient (patient 2) had both LCIS and IDC and another (patient 5) had both DCIS and LCIS. The TNM stages recorded were major in TisN0M0, T1aN0M0 stage to T1bN0M0. A T1aN1M0 tumor was also noted.<fig id="Fig2"><label>Figure 2</label><caption><p>
<bold>Postoperative photograph of patient 26.</bold> This patient had centrally located breast cancer arising from a fibroadenoma diagnosed before surgery. She was treated with endoscopically assisted nipple-sparing mastectomy combined with immediate breast reconstruction with a gel implant. Photograph was taken 3&#xA0;months after surgery.</p></caption><graphic xlink:href="12957_2014_1863_Fig2_HTML" id="d30e2106"/></fig></p>
      <table-wrap id="Tab2">
        <label>Table 2</label>
        <caption>
          <p>
<bold>Demographic and clinical features</bold>
<sup><bold>a</bold></sup>
</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th>Characteristics (
<bold><italic>N</italic></bold>
=30)</th>
              <th>Data</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td>Mean age (range), yr</td>
              <td align="center">46.9 (27 to 80)</td>
            </tr>
            <tr>
              <td>Mean tumor size (range), cm</td>
              <td align="center">2.46 (0.8 to 5.1)</td>
            </tr>
            <tr>
              <td>Female gender, <italic>n</italic> (%)</td>
              <td align="center">30 (100%)</td>
            </tr>
            <tr>
              <td>Mean tumor follow-up duration (range) months</td>
              <td align="center">61.2 (0.5 to 600)</td>
            </tr>
            <tr>
              <td>Histology<sup>b</sup> (<italic>N</italic> =30), <italic>n</italic> (%)</td>
              <td align="center"/>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;DCIS</td>
              <td align="center">7 (23.3%)</td>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;LCIS</td>
              <td align="center">5 (16.7%)</td>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;IDC</td>
              <td align="center">16 (53.3%)</td>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;ILC</td>
              <td align="center">4 (13.3%)</td>
            </tr>
            <tr>
              <td>TNM stage (<italic>N</italic> =30), <italic>n</italic> (%)</td>
              <td align="center"/>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;TisN0M0</td>
              <td align="center">10 (33.3%)</td>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;T1aN0M0</td>
              <td align="center">1 (3.3%)</td>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;T1bN0M0</td>
              <td align="center">3 (10.0%)</td>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;T1aN1M0</td>
              <td align="center">1 (3.3%)</td>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;Unclear</td>
              <td align="center">15 (30%)</td>
            </tr>
            <tr>
              <td>Operation method (<italic>N</italic> =30), <italic>n</italic> (%)</td>
              <td align="center"/>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;BCS</td>
              <td align="center">20 (66.7%)</td>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;Mastectomy</td>
              <td align="center">9 (30.0%)</td>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;No data</td>
              <td align="center">1 (3.3%)</td>
            </tr>
            <tr>
              <td>Lymph node dissection (<italic>N</italic> =30), <italic>n</italic> (%)</td>
              <td align="center"/>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;Axillary clearance</td>
              <td align="center">8 (26.7%)</td>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;Sentinel lymph node dissection</td>
              <td align="center">11 (36.7%)</td>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;Not done</td>
              <td align="center">1 (3.3%)</td>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;No data</td>
              <td align="center">10 (33.3%)</td>
            </tr>
            <tr>
              <td>Lymph node (<italic>N</italic> =30), <italic>n</italic> (%)</td>
              <td align="center"/>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;Metastasis</td>
              <td align="center">5 (16.7%)</td>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;Negative</td>
              <td align="center">16 (53.3%)</td>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;No data</td>
              <td align="center">9 (30.0%)</td>
            </tr>
            <tr>
              <td>Receptor status</td>
              <td align="center"/>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;ER&#x2009;+&#x2009;(<italic>n</italic> =16)</td>
              <td align="center">11 (68.8%)</td>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;PR&#x2009;+&#x2009;(<italic>n</italic> =16)</td>
              <td align="center">10 (62.5%)</td>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;HER2+ (<italic>n</italic> =10)</td>
              <td align="center">1 (10.0%)</td>
            </tr>
            <tr>
              <td>Further management</td>
              <td align="center"/>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;Chemotherapy (<italic>n</italic> =10)</td>
              <td align="center">4 (40.0%)</td>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;Hormone therapy (<italic>n</italic> =10)</td>
              <td align="center">6 (60.0%)</td>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;Radiation therapy (<italic>n</italic> =11)</td>
              <td align="center">5 (45.5%)</td>
            </tr>
            <tr>
              <td>Outcome</td>
              <td align="center"/>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;Average follow-up (range), months</td>
              <td align="center">21.9 (5 to 59)</td>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;Recurrence (<italic>n</italic> =16)</td>
              <td align="center">1 (6.3%)</td>
            </tr>
            <tr>
              <td>&#x2003;&#xA0;Distant metastasis<sup>c</sup> (<italic>n</italic> =16)</td>
              <td align="center">1 (6.3%)</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>
<sup>a</sup>BCS, Breast-conserving surgery; DCIS, Ductal carcinoma <italic>in situ</italic>; ER, Estrogen receptor; HER2, Human epidermal growth factor receptor 2; IDC, Invasive ductal carcinoma; ILC, Invasive lobular carcinoma; LCIS, Lobular carcinoma <italic>in situ</italic>; PR, Progesterone receptor; TNM, Tumor, node, metastasis. <sup>b</sup>One patient had both LCIS and IDC, and another had both DCIS and LCIS. <sup>c</sup>Distant metastasis was noted at cancer diagnosis.</p>
        </table-wrap-foot>
      </table-wrap>
      <p>Regarding hormone receptor status and HER2 status, there were only 16 patients (53.3%) with data mentioned about ER and PR status. Eleven (68.8%) of these sixteen patients had ER&#x2009;+&#x2009;breast cancer, and ten patients (62.5%) had PR&#x2009;+&#x2009;cancer. Of ten patients with known HER2 status, only one patient (10.0%; patient 16) was found to have HER2-overexpressing breast cancer. Among 11 patients with hormone receptor&#x2013;positive BcaFad, 6 patients (54.5%) received tamoxifen treatment. Four (80%) of five patients with lymph node metastasis received chemotherapy.</p>
      <p>Nine patients were treated with mastectomy, and another twenty patients were treated with BCS. However, only four (20.0%) of the twenty patients who underwent BCS received radiotherapy
[<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Patient 17 received radiotherapy to the chest wall following a mastectomy performed for lymph node metastasis
[<xref ref-type="bibr" rid="CR27">27</xref>]. Of the four BCS patients with IDC, only one (25.0%) received radiation therapy. In addition, among six BCS patients with DCIS, only two (33.3%) received radiotherapy. Of fifteen patients with descriptions of outcome and distant metastasis, only one (patient 22) was found to have lung metastasis at diagnosis. Another patient (patient 14) had a local recurrence 5&#xA0;months after surgery.</p>
    </sec>
    <sec id="Sec4" sec-type="discussion">
      <title>Discussion</title>
      <p>It is very unusual for a carcinoma of the breast to arise within a fibroadenoma. In this report, we present our 6 cases together with 24 previously reported cases for a collective case analysis. Among these 30 cases, the mean age at diagnosis of BcaFad was 46.9&#xA0;years, which was older than that at diagnosis of benign fibroadenoma (age range from 20s to 30s)
[<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. The mean duration from finding a fibroadenoma to surgical excision was 61.2&#xA0;months (range from 0.5 to 600&#xA0;months). This long duration can be explained by the large size of the breast tumors (mean 2.46&#xA0;cm) in this group of patients. This tumor size refers to the diameter of the fibroadenoma in which the malignant component was identified. In our present study, most BcaFads were predominantly found to be small cancers in relatively large fibroadenomas. However, the tumor size was not reported in most of the reviews we included, so we could not present the actual pathologic tumor size in each individual (Tables&#xA0;
<xref rid="Tab1" ref-type="table">1</xref> and
<xref rid="Tab2" ref-type="table">2</xref>). Half of the data did not contain details regarding TNM stage; the other half were for stages TisN0M0, T1aN0M0, T1bN0M0 and T1aN1M0. However, we could assume that most of the limited data were for early breast cancer according to the descriptions of histology.</p>
      <p>According to our collective case analysis, the major histological type of BcaFad was IDC (53.3%), followed by DCIS (23.3%), LCIS (16.7%) and ILC (13.3%) (Table&#xA0;
<xref rid="Tab2" ref-type="table">2</xref>). These findings are not consistent with previous reports that BcaFads were mainly carcinomas <italic>in situ</italic> (66.9% LCIS and 12.4% DCIS), followed by invasive carcinoma (11% IDC and 3.4% ILC)
[<xref ref-type="bibr" rid="CR9">9</xref>]. This discrepancy might be due to selection bias. Our present study is a collective analysis of case reports in the literature. Patients with invasive carcinoma inside fibroadenoma are rare and tend to be presented as case reports. In our six cases, the cancerous parts of the tumors were limited within the capsule of the underlying fibroadenoma without extension to peripheral breast tissue. In those BcaFad with DCIS, the DCIS was limited inside the fibroadenoma without invasion into the adjacent nonfibroadenoma breast tissue. In the LCIS-containing tumors, three patients had pure LCIS, one patient had both IDC and LCIS and two patients had both ILC and LCIS. None of them were found to have bilateral breast cancer. In our present analysis, we found that LCIS may be associated with invasive breast cancer.</p>
      <p>In this study, 20 (66.7%) of 30 patients with BcaFad could be managed by BCS, and another 9 patients (30.0%) received mastectomies. The treatment principle for benign fibroadenomas is surgical excision with a thin ring of benign breast tissue
[<xref ref-type="bibr" rid="CR5">5</xref>], and breast conservation is usually feasible. BcaFad is usually found incidentally during the pathologic check when the breast tumor is being excised. This could explain why most of these patients (66.7%) received BCS as their surgical treatment. This breast-conserving rate is compatible with the reported data (19.6-58.0%) in the management of breast cancer with the same tumor size in the NASBP B-06 trial (National Surgical Adjuvant Breast and Bowel Project) and the National Cancer Database in the United States
[<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>].</p>
      <p>Another reason for the high breast-conserving rate of the patients in this group is that most fibroadenomas are well-defined, with a "capsule"
[<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. If the initial resection margin is free of cancer or only LCIS is inside the fibroadenoma, then a tumorectomy or lumpectomy alone may be sufficient
[<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. These facts could explain why the high rate of patients with BcaFad received BCS in this study. If the resection margin is involved or close, however, then a further wide excision may be needed
[<xref ref-type="bibr" rid="CR7">7</xref>].</p>
      <p>Mastectomy (30.0% in this study) may still be needed in some circumstances&#x2014;usually in large, multifocal or central located tumor
[<xref ref-type="bibr" rid="CR39">39</xref>]. One of our six patients (patient 26) received an endoscopically assisted, nipple-sparing mastectomy combined with immediate breast reconstruction using a gel implant because of the large size and central location of the breast tumor (Figure&#xA0;
<xref rid="Fig2" ref-type="fig">2</xref>). Owing to the favorable prognosis, mastectomy with immediate breast reconstruction can be considered in patients with BcaFad when a mastectomy is needed.</p>
      <p>Radiotherapy can effectively reduce local recurrence, and this reduction in disease relapse may translate to prolonged overall survival
[<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. Nowadays, there is an established rule that, in order to decrease the risk of local recurrence, radiotherapy should be delivered to breast cancer patients receiving BCS
[<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Should patients with BcaFad have to receive radiotherapy after partial mastectomy? Tiu <italic>et al</italic>.
[<xref ref-type="bibr" rid="CR41">41</xref>] stated that BcaFad behaves like breast cancer at the same stage and that therefore the treatment should follow the same modality. However, only four (20.0%) of the BCS patients received radiotherapy according to our collective case analysis
[<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Of four BCS patients with IDC, only one patient (25.0%; patient 15) received radiation therapy. In addition, among six BCS patients with DCIS, only two (33.3%) received radiotherapy.</p>
      <p>According to our collective case analysis in this study, it seemed as though not all surgeons agreed that radiotherapy should be delivered to patients with BcaFad after BCS. To date, to our knowledge, no randomized controlled trials or large cohort studies have been conducted to answer this question. According to our literature review (Figure&#xA0;
<xref rid="Fig1" ref-type="fig">1</xref>), fewer than 250 patients with BcaFad have been reported to date, and only 8 of them were reported to have received radiotherapy
[<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. Whether radiotherapy is necessary for BcaFad patients after BCS is still unknown; more solid evidence is needed to establish the role of radiotherapy for this particular group of patients. To the best of our knowledge, radiotherapy seems optional rather than mandatory for BcaFad patients after partial mastectomy.</p>
      <p>Owing to the limitations of a literature review, hormonal and HER2 receptor status was incompletely reported. In our collective case analysis, the incidence of hormone receptor&#x2013;positive BcaFad was 68.8% ER&#x2009;+&#x2009;and 62.5% PR+, which is compatible with of the incidence in common types of breast cancer (range, approximately 60% to 90%)
[<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. However, the rate of HER2 overexpression was only 10.0%, which is a little lower than that of common types of breast cancer (approximately 15% to 25%)
[<xref ref-type="bibr" rid="CR44">44</xref>&#x2013;<xref ref-type="bibr" rid="CR46">46</xref>].</p>
      <p>According to reports in the literature, most BcaFad cases are carcinoma <italic>in situ</italic> (79.3%), and less than 15% are invasive carcinomas
[<xref ref-type="bibr" rid="CR9">9</xref>]. BcaFad with lymph node metastasis is unusual, but can still occur
[<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR48">48</xref>]. A sentinel lymph node biopsy should be performed if there is a pathologic confirmation of the presence of invasive carcinoma of BcaFad. Furthermore, axillary lymph node dissection should be performed in the presence of lymph node metastasis. Lymph node metastasis, rather than tumor size or hormone status, is the main concern underlying the use of chemotherapy for patients with BcaFad
[<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR49">49</xref>].</p>
      <p>The prognosis for patients with BcaFad was reported to be more favorable than that in other common types of breast cancer
[<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. In our collective case analysis, among 15 patients with descriptions of long-term results, 1 patient (6.67%, patient 14) had local recurrence 5&#xA0;months after surgery
[<xref ref-type="bibr" rid="CR24">24</xref>] and another (patient 22) was found to have lung metastasis
[<xref ref-type="bibr" rid="CR32">32</xref>] when diagnosed with BcaFad. Death caused by BcaFad was uncommon, but still can occur in cases of invasive carcinomas at a late stage
[<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>].</p>
    </sec>
    <sec id="Sec5" sec-type="conclusions">
      <title>Conclusions</title>
      <p>BcaFad is an infrequent malignancy and carries a favorable prognosis. Most BcaFads can be managed with BCS, and radiotherapy can be delivered optionally even when patient has undergone BCS. A sentinel lymph node biopsy should be performed if invasive carcinoma is present. In the presence of lymph node metastasis, chemotherapy should be considered to prevent distant metastasis.</p>
    </sec>
    <sec id="Sec6">
      <title>Authors&#x2019; information</title>
      <p>YTW, STC, DRC, SJK and HWL: Comprehensive Breast Cancer Center, Changhua Christian Hospital, Changhua, Taiwan. YTW: Department of Surgery, Sinying Hospital, Ministry of Health and Welfare, Tainan, Taiwan. CJC: Department of Surgical Pathology, Changhua Christian Hospital, Changhua, Taiwan. YLK: Department of Surgery, National Cheng-Kung University Hospital, Tainan, Taiwan. LMT: Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-list>
          <def-item>
            <term>BcaFad</term>
            <def>
              <p>Breast cancer arising within fibroadenoma</p>
            </def>
          </def-item>
          <def-item>
            <term>BCS</term>
            <def>
              <p>Breast-conserving surgery</p>
            </def>
          </def-item>
          <def-item>
            <term>DCIS</term>
            <def>
              <p>Ductal carcinoma <italic>in situ</italic></p>
            </def>
          </def-item>
          <def-item>
            <term>ER</term>
            <def>
              <p>Estrogen receptor</p>
            </def>
          </def-item>
          <def-item>
            <term>IDC</term>
            <def>
              <p>Invasive ductal carcinoma</p>
            </def>
          </def-item>
          <def-item>
            <term>HER2</term>
            <def>
              <p>Human epidermal growth factor receptor 2</p>
            </def>
          </def-item>
          <def-item>
            <term>ILC</term>
            <def>
              <p>Invasive lobular carcinoma</p>
            </def>
          </def-item>
          <def-item>
            <term>LCIS</term>
            <def>
              <p>Lobular carcinoma <italic>in situ</italic></p>
            </def>
          </def-item>
          <def-item>
            <term>PR</term>
            <def>
              <p>Progesterone receptor.</p>
            </def>
          </def-item>
        </def-list>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>HWL, STC and YTW designed the study. YTW, STC, YLK, LMT and CJC collected data. YTW, HWL, YLK and CJC prepared the manuscript. DRC, SJK and LMJ revised the manuscript. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <p>This study was supported by the research program at Changhua Christian Hospital. The authors thank the research nurse specialists of Changhua Christian Hospital, National Cheng-Kung University Hospital and Taipei Veterans General Hospital.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carty</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Carter</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rubin</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ravichandran</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Royle</surname>
              <given-names>GT</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Management of fibroadenoma of the breast</article-title>
          <source>Ann R Coll Surg Engl</source>
          <year>1995</year>
          <volume>77</volume>
          <fpage>127</fpage>
          <lpage>130</lpage>
          <pub-id pub-id-type="pmid">7793802</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Foster</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Garrahan</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Fibroadenoma of the breast: a clinical and pathological study</article-title>
          <source>J R Coll Surg Edinb</source>
          <year>1988</year>
          <volume>33</volume>
          <fpage>16</fpage>
          <lpage>19</lpage>
          <pub-id pub-id-type="pmid">3418570</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cant</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Madden</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Coleman</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Dent</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <article-title>Non-operative management of breast masses diagnosed as fibroadenoma</article-title>
          <source>Br J Surg</source>
          <year>1995</year>
          <volume>82</volume>
          <fpage>792</fpage>
          <lpage>794</lpage>
          <pub-id pub-id-type="doi">10.1002/bjs.1800820624</pub-id>
          <pub-id pub-id-type="pmid">7627513</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gordon</surname>
              <given-names>PB</given-names>
            </name>
            <name>
              <surname>Gagnon</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Lanzkowsky</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Solid breast masses diagnosed as fibroadenoma at fine-needle aspiration biopsy: acceptable rates of growth at long-term follow-up</article-title>
          <source>Radiology</source>
          <year>2003</year>
          <volume>229</volume>
          <fpage>233</fpage>
          <lpage>238</lpage>
          <pub-id pub-id-type="doi">10.1148/radiol.2291010282</pub-id>
          <pub-id pub-id-type="pmid">14519878</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Greenberg</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Skornick</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kaplan</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Management of breast fibroadenomas</article-title>
          <source>J Gen Intern Med</source>
          <year>1998</year>
          <volume>13</volume>
          <fpage>640</fpage>
          <lpage>645</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1525-1497.1998.cr188.x</pub-id>
          <pub-id pub-id-type="pmid">9754521</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Desch&#xEA;nes</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Jacob</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fabia</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Christen</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Beware of breast fibroadenomas in middle-aged women</article-title>
          <source>Can J Surg</source>
          <year>1985</year>
          <volume>28</volume>
          <fpage>372</fpage>
          <lpage>374</lpage>
          <pub-id pub-id-type="pmid">2990650</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dupont</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Page</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Parl</surname>
              <given-names>FF</given-names>
            </name>
            <name>
              <surname>Vnencak-Jones</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Plummer</surname>
              <given-names>WD</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Rados</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Schuyler</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
          <article-title>Long-term risk of breast cancer in women with fibroadenoma</article-title>
          <source>N Engl J Med</source>
          <year>1994</year>
          <volume>331</volume>
          <fpage>10</fpage>
          <lpage>15</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJM199407073310103</pub-id>
          <pub-id pub-id-type="pmid">8202095</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buzanowski-Konakry</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>EG</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Payne</surname>
              <given-names>WS</given-names>
            </name>
          </person-group>
          <article-title>Lobular carcinoma arising in fibroadenoma of the breast</article-title>
          <source>Cancer</source>
          <year>1975</year>
          <volume>35</volume>
          <fpage>450</fpage>
          <lpage>456</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(197502)35:2&lt;450::AID-CNCR2820350223&gt;3.0.CO;2-R</pub-id>
          <pub-id pub-id-type="pmid">1111920</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fukuda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nagao</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nishimura</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Matsuda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Baba</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ueno</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Morinaga</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Omachi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hamada</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Carcinoma arising in fibroadenoma of the breast&#x2013;a case report and review of the literature</article-title>
          <source>Jpn J Surg</source>
          <year>1989</year>
          <volume>19</volume>
          <fpage>593</fpage>
          <lpage>596</lpage>
          <pub-id pub-id-type="doi">10.1007/BF02471669</pub-id>
          <pub-id pub-id-type="pmid">2593394</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goldhirsch</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Coates</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Gelber</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Th&#xFC;rlimann</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Senn</surname>
              <given-names>HJ</given-names>
            </name>
            <collab>Panel members</collab>
          </person-group>
          <article-title>Strategies for subtypes&#x2014;dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011</article-title>
          <source>Ann Oncol</source>
          <year>2011</year>
          <volume>22</volume>
          <fpage>1736</fpage>
          <lpage>1747</lpage>
          <pub-id pub-id-type="doi">10.1093/annonc/mdr304</pub-id>
          <pub-id pub-id-type="pmid">21709140</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>Early Breast Cancer Trialists&#x2019; Collaborative Group (EBCTCG)</collab>
          </person-group>
          <article-title>Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials</article-title>
          <source>Lancet</source>
          <year>2005</year>
          <volume>366</volume>
          <fpage>2087</fpage>
          <lpage>2106</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(05)67887-7</pub-id>
          <pub-id pub-id-type="pmid">16360786</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>Early Breast Cancer Trialists&#x2019; Collaborative Group (EBCTCG)</collab>
          </person-group>
          <article-title>Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials</article-title>
          <source>Lancet</source>
          <year>2011</year>
          <volume>378</volume>
          <fpage>1707</fpage>
          <lpage>1716</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(11)60993-8</pub-id>
          <pub-id pub-id-type="pmid">22019144</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Theriault</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Carlson</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Allred</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>BO</given-names>
            </name>
            <name>
              <surname>Burstein</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Edge</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Farrar</surname>
              <given-names>WB</given-names>
            </name>
            <name>
              <surname>Forero</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Giordano</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Goldstein</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Gradishar</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Hayes</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Hudis</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Isakoff</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Ljung</surname>
              <given-names>BME</given-names>
            </name>
            <name>
              <surname>Mankoff</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Marcom</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Mayer</surname>
              <given-names>IA</given-names>
            </name>
            <name>
              <surname>McCormick</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Pierce</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Reed</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Schwartzberg</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Soliman</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Somlo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ward</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Wolff</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Zellars</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Shead</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>R</given-names>
            </name>
            <collab>National Comprehensive Cancer Network</collab>
          </person-group>
          <article-title>NCCN Guidelines Insights: Breast cancer, version 3.2013: featured updates to the NCCN guidelines</article-title>
          <source>J Natl Compr Canc Netw</source>
          <year>2013</year>
          <volume>11</volume>
          <fpage>753</fpage>
          <lpage>761</lpage>
          <pub-id pub-id-type="pmid">23847214</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kurosumi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Itokazu</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mamiya</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kishi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Takayama</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nagasawa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kurihara</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Suemasu</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Higashi</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Invasive ductal carcinoma with a predominant intraductal component arising in a fibroadenoma of the breast</article-title>
          <source>Pathol Int</source>
          <year>1994</year>
          <volume>44</volume>
          <fpage>874</fpage>
          <lpage>877</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1440-1827.1994.tb01687.x</pub-id>
          <pub-id pub-id-type="pmid">7866572</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sarela</surname>
              <given-names>AI</given-names>
            </name>
            <name>
              <surname>Madvanur</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Soonawala</surname>
              <given-names>ZF</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>HK</given-names>
            </name>
            <name>
              <surname>Pandit</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Samsi</surname>
              <given-names>AB</given-names>
            </name>
          </person-group>
          <article-title>Carcinoma in a fibroadenoma</article-title>
          <source>J Postgrad Med</source>
          <year>1995</year>
          <volume>41</volume>
          <fpage>19</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="pmid">10740697</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shah</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Pathak</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Banerjee</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Kaul</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Niazi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Girishkumar</surname>
              <given-names>HT</given-names>
            </name>
          </person-group>
          <article-title>Lobular carcinoma-in-situ within a fibroadenoma of the breast</article-title>
          <source>Postgrad Med J</source>
          <year>1999</year>
          <volume>75</volume>
          <fpage>293</fpage>
          <lpage>294</lpage>
          <pub-id pub-id-type="pmid">10533636</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yano</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ueno</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kamma</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tsunoda</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hara</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yashiro</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Aiyoshi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Hukazawa</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Non-invasive lobular carcinoma within a fibroadenoma, a preoperatively diagnosed case</article-title>
          <source>Breast Cancer</source>
          <year>2001</year>
          <volume>8</volume>
          <fpage>70</fpage>
          <lpage>73</lpage>
          <pub-id pub-id-type="doi">10.1007/BF02967481</pub-id>
          <pub-id pub-id-type="pmid">11180769</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuijper</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Preisler-Adams</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Rahusen</surname>
              <given-names>FD</given-names>
            </name>
            <name>
              <surname>Gille</surname>
              <given-names>JJP</given-names>
            </name>
            <name>
              <surname>van der Wall</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>van Diest</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Multiple fibroadenomas harbouring carcinoma in situ in a woman with a family history of breast/ovarian cancer</article-title>
          <source>J Clin Pathol</source>
          <year>2002</year>
          <volume>55</volume>
          <fpage>795</fpage>
          <lpage>797</lpage>
          <pub-id pub-id-type="doi">10.1136/jcp.55.10.795</pub-id>
          <pub-id pub-id-type="pmid">12354814</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abe</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hanasawa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Naitoh</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Endo</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tani</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kushima</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Invasive ductal carcinoma within a fibroadenoma of the breast</article-title>
          <source>Int J Clin Oncol</source>
          <year>2004</year>
          <volume>9</volume>
          <fpage>334</fpage>
          <lpage>338</lpage>
          <pub-id pub-id-type="doi">10.1007/s10147-004-0401-9</pub-id>
          <pub-id pub-id-type="pmid">15375712</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stafyla</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Kotsifopoulos</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Grigoriades</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kassaras</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Sakorafas</surname>
              <given-names>GH</given-names>
            </name>
          </person-group>
          <article-title>Lobular carcinoma in situ of the breast within a fibroadenoma: a case report</article-title>
          <source>Gynecol Oncol</source>
          <year>2004</year>
          <volume>94</volume>
          <fpage>572</fpage>
          <lpage>574</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ygyno.2004.04.031</pub-id>
          <pub-id pub-id-type="pmid">15297206</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shin</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>YJ</given-names>
            </name>
          </person-group>
          <article-title>Microinvasive ductal carcinoma arising within a fibroadenoma: a case report</article-title>
          <source>Acta Radiol</source>
          <year>2006</year>
          <volume>47</volume>
          <fpage>643</fpage>
          <lpage>645</lpage>
          <pub-id pub-id-type="doi">10.1080/02841850600698838</pub-id>
          <pub-id pub-id-type="pmid">16950696</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yuen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Uematsu</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kasami</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Two cases of small infiltrating lobular carcinomas mimicking fibroadenoma on breast MRI</article-title>
          <source>Breast J</source>
          <year>2007</year>
          <volume>13</volume>
          <fpage>616</fpage>
          <lpage>617</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1524-4741.2007.00494.x</pub-id>
          <pub-id pub-id-type="pmid">17983407</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borecky</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Rickard</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Preoperative diagnosis of carcinoma within fibroadenoma on screening mammograms</article-title>
          <source>J Med Imaging Radiat Oncol</source>
          <year>2008</year>
          <volume>52</volume>
          <fpage>64</fpage>
          <lpage>67</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1440-1673.2007.01913.x</pub-id>
          <pub-id pub-id-type="pmid">18373829</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gashi-Luci</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Limani</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Kurshumliu</surname>
              <given-names>FI</given-names>
            </name>
          </person-group>
          <article-title>Invasive ductal carcinoma within fibroadenoma: a case report</article-title>
          <source>Cases J</source>
          <year>2009</year>
          <volume>2</volume>
          <fpage>174</fpage>
          <pub-id pub-id-type="doi">10.1186/1757-1626-2-174</pub-id>
          <pub-id pub-id-type="pmid">19946485</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khandelwal</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Tandon</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yashwant</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kulshreshtha</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Aeron</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Bhatnagar</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bansal</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Saxena</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Carcinoma developing in a fibroadenoma in a woman with a family history of breast cancer: a case report and review of literature</article-title>
          <source>Cases J</source>
          <year>2009</year>
          <volume>2</volume>
          <fpage>9348</fpage>
          <pub-id pub-id-type="doi">10.1186/1757-1626-2-9348</pub-id>
          <pub-id pub-id-type="pmid">20072677</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iyengar</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Peh</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Yip</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Vijayananthan</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Infiltrating duct carcinoma within a fibroadenoma</article-title>
          <source>Indian J Cancer</source>
          <year>2009</year>
          <volume>46</volume>
          <fpage>244</fpage>
          <lpage>246</lpage>
          <pub-id pub-id-type="doi">10.4103/0019-509X.52964</pub-id>
          <pub-id pub-id-type="pmid">19574682</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rao</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Latha</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ravi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Thanka</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Ductal carcinoma in a multiple fibroadenoma: diagnostic inaccuracies</article-title>
          <source>J Cancer Res Ther</source>
          <year>2010</year>
          <volume>6</volume>
          <fpage>385</fpage>
          <lpage>387</lpage>
          <pub-id pub-id-type="doi">10.4103/0973-1482.73350</pub-id>
          <pub-id pub-id-type="pmid">21119286</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Petersson</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Tan</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Putti</surname>
              <given-names>TC</given-names>
            </name>
          </person-group>
          <article-title>Low-grade ductal carcinoma in situ and invasive mammary carcinoma with columnar cell morphology arising in a complex fibroadenoma in continuity with columnar cell change and flat epithelial atypia</article-title>
          <source>Int J Surg Pathol</source>
          <year>2010</year>
          <volume>18</volume>
          <fpage>352</fpage>
          <lpage>357</lpage>
          <pub-id pub-id-type="doi">10.1177/1066896909355811</pub-id>
          <pub-id pub-id-type="pmid">20643672</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kato</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Omatsu</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Matsumura</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hosoda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kubota</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Oyama-Manabe</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Terae</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shirato</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Dynamic MR findings of ductal carcinoma <italic>in situ</italic> within a fibroadenoma</article-title>
          <source>Magn Reson Med Sci</source>
          <year>2011</year>
          <volume>10</volume>
          <fpage>129</fpage>
          <lpage>132</lpage>
          <pub-id pub-id-type="doi">10.2463/mrms.10.129</pub-id>
          <pub-id pub-id-type="pmid">21720115</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ooe</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Takahara</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sumiyoshi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shiba</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kawai</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Preoperative diagnosis of ductal carcinoma <italic>in situ</italic> arising within a mammary fibroadenoma: a case report</article-title>
          <source>Jpn J Clin Oncol</source>
          <year>2011</year>
          <volume>41</volume>
          <fpage>918</fpage>
          <lpage>923</lpage>
          <pub-id pub-id-type="doi">10.1093/jjco/hyr075</pub-id>
          <pub-id pub-id-type="pmid">21693482</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tajima</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kanemaki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kurihara</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Okamoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Shimamoto</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Okazaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Okuda</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kawahara</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Nakajima</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Fukuda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Maeda</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>A case of a fibroadenoma coexisting with an invasive lobular carcinoma in the breast</article-title>
          <source>Breast Cancer</source>
          <year>2011</year>
          <volume>18</volume>
          <fpage>319</fpage>
          <lpage>323</lpage>
          <pub-id pub-id-type="doi">10.1007/s12282-009-0122-z</pub-id>
          <pub-id pub-id-type="pmid">19543793</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abu-Rahmeh</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Nseir</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Naroditzky</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Invasive ductal carcinoma within fibroadenoma and lung metastases</article-title>
          <source>Int J Gen Med</source>
          <year>2012</year>
          <volume>5</volume>
          <fpage>19</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="doi">10.2147/IJGM.S26115</pub-id>
          <pub-id pub-id-type="pmid">22259257</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jahan</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ghosh</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Rahman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Khanam</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Fibroadenoma with foci of infiltrating ductal carcinoma</article-title>
          <source>JOM J Medicine</source>
          <year>2012</year>
          <volume>13</volume>
          <fpage>115</fpage>
          <lpage>117</lpage>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Butler</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pinsky</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Jorns</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Alveolar variant of invasive lobular carcinoma in a fibroadenoma</article-title>
          <source>Breast J</source>
          <year>2012</year>
          <volume>18</volume>
          <fpage>613</fpage>
          <lpage>614</lpage>
          <pub-id pub-id-type="doi">10.1111/tbj.12016</pub-id>
          <pub-id pub-id-type="pmid">23009384</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuijper</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mommers</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>van der Wall</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>van Diest</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Histopathology of fibroadenoma of the breast</article-title>
          <source>Am J Clin Pathol</source>
          <year>2001</year>
          <volume>115</volume>
          <fpage>736</fpage>
          <lpage>742</lpage>
          <pub-id pub-id-type="doi">10.1309/F523-FMJV-W886-3J38</pub-id>
          <pub-id pub-id-type="pmid">11345838</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Farrow</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Hunt</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Samet</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Geographic variation in the treatment of localized breast cancer</article-title>
          <source>N Engl J Med</source>
          <year>1992</year>
          <volume>326</volume>
          <fpage>1097</fpage>
          <lpage>1101</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJM199204233261701</pub-id>
          <pub-id pub-id-type="pmid">1552910</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bland</surname>
              <given-names>KI</given-names>
            </name>
            <name>
              <surname>Menck</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Scott-Conner</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Morrow</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Winchester</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Winchester</surname>
              <given-names>DP</given-names>
            </name>
          </person-group>
          <article-title>The National Cancer Data Base 10-year survey of breast carcinoma treatment at hospitals in the United States</article-title>
          <source>Cancer</source>
          <year>1998</year>
          <volume>83</volume>
          <fpage>1262</fpage>
          <lpage>1273</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1097-0142(19980915)83:6&lt;1262::AID-CNCR28&gt;3.0.CO;2-2</pub-id>
          <pub-id pub-id-type="pmid">9740094</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosen</surname>
              <given-names>PP</given-names>
            </name>
            <name>
              <surname>Kosloff</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lieberman</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Adair</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Braun</surname>
              <given-names>DW</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Lobular carcinoma in situ of the breast: detailed analysis of 99 patients with average follow-up of 24&#xA0;years</article-title>
          <source>Am J Surg Pathol</source>
          <year>1978</year>
          <volume>2</volume>
          <fpage>225</fpage>
          <lpage>251</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-197809000-00001</pub-id>
          <pub-id pub-id-type="pmid">210682</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yoshida</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Takaoka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fukumoto</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Carcinoma arising in fibroadenoma: case report and review of the world literature</article-title>
          <source>J Surg Oncol</source>
          <year>1985</year>
          <volume>29</volume>
          <fpage>132</fpage>
          <lpage>140</lpage>
          <pub-id pub-id-type="doi">10.1002/jso.2930290213</pub-id>
          <pub-id pub-id-type="pmid">4079388</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fisher</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bryant</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Margolese</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Deutsch</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fisher</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Jeong</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Wolmark</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer</article-title>
          <source>N Engl J Med</source>
          <year>2002</year>
          <volume>347</volume>
          <fpage>1233</fpage>
          <lpage>1241</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMoa022152</pub-id>
          <pub-id pub-id-type="pmid">12393820</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tiu</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Chou</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Chiou</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Chiang</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Tseng</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>HK</given-names>
            </name>
            <name>
              <surname>Chiou</surname>
              <given-names>HJ</given-names>
            </name>
          </person-group>
          <article-title>Development of a carcinoma in situ in a fibroadenoma: color Doppler sonographic demonstration</article-title>
          <source>J Ultrasound Med</source>
          <year>2006</year>
          <volume>25</volume>
          <fpage>1335</fpage>
          <lpage>1338</lpage>
          <pub-id pub-id-type="pmid">16998108</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sastre-Garau</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Jouve</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Asselain</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Vincent-Salomon</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Beuzeboc</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Dorval</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Durand</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Fourquet</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pouillart</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Infiltrating lobular carcinoma of the breast: clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns</article-title>
          <source>Cancer</source>
          <year>1996</year>
          <volume>77</volume>
          <fpage>113</fpage>
          <lpage>120</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1097-0142(19960101)77:1&lt;113::AID-CNCR19&gt;3.0.CO;2-8</pub-id>
          <pub-id pub-id-type="pmid">8630916</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zafrani</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Aubriot</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Mouret</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>De Cr&#xE9;moux</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>De Rycke</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nicolas</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Boudou</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Vincent-Salomon</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Magdel&#xE9;nat</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sastre-Garau</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases</article-title>
          <source>Histopathology</source>
          <year>2000</year>
          <volume>37</volume>
          <fpage>536</fpage>
          <lpage>545</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-2559.2000.01006.x</pub-id>
          <pub-id pub-id-type="pmid">11122436</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaptain</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tan</surname>
              <given-names>LK</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Her-2/<italic>neu</italic> and breast cancer</article-title>
          <source>Diagn Mol Pathol</source>
          <year>2001</year>
          <volume>10</volume>
          <fpage>139</fpage>
          <lpage>152</lpage>
          <pub-id pub-id-type="doi">10.1097/00019606-200109000-00001</pub-id>
          <pub-id pub-id-type="pmid">11552716</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bundred</surname>
              <given-names>NJ</given-names>
            </name>
          </person-group>
          <article-title>Prognostic and predictive factors in breast cancer</article-title>
          <source>Cancer Treat Rev</source>
          <year>2001</year>
          <volume>27</volume>
          <fpage>137</fpage>
          <lpage>142</lpage>
          <pub-id pub-id-type="doi">10.1053/ctrv.2000.0207</pub-id>
          <pub-id pub-id-type="pmid">11417963</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ravdin</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Chamness</surname>
              <given-names>GC</given-names>
            </name>
          </person-group>
          <article-title>The c-<italic>erbB</italic>-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers&#x2013;a review</article-title>
          <source>Gene</source>
          <year>1995</year>
          <volume>159</volume>
          <fpage>19</fpage>
          <lpage>27</lpage>
          <pub-id pub-id-type="doi">10.1016/0378-1119(94)00866-Q</pub-id>
          <pub-id pub-id-type="pmid">7607568</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harrington</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Malignant changes in fibroadenoma of the mammary gland</article-title>
          <source>Surg Gynecol Obstet</source>
          <year>1940</year>
          <volume>70</volume>
          <fpage>615</fpage>
          <lpage>619</lpage>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morimoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Komaki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sasa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Monden</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kumagai</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Otsuka</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>The coexistence of lobular carcinoma in a fibroadenoma with a malignant phyllodes tumor in the opposite breast: report of a case</article-title>
          <source>Surg Today</source>
          <year>1993</year>
          <volume>23</volume>
          <fpage>656</fpage>
          <lpage>660</lpage>
          <pub-id pub-id-type="doi">10.1007/BF00311918</pub-id>
          <pub-id pub-id-type="pmid">8396471</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ben Hassouna</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Damak</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ben Slama</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chargui</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ben Dhiab</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Khomsi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Gamoud</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Boussen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Rahal</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Breast carcinoma arising within fibroadenomas: report of four observations</article-title>
          <source>Tunis Med</source>
          <year>2007</year>
          <volume>85</volume>
          <fpage>891</fpage>
          <lpage>895</lpage>
          <pub-id pub-id-type="pmid">18236815</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pick</surname>
              <given-names>PW</given-names>
            </name>
            <name>
              <surname>Iossifides</surname>
              <given-names>IA</given-names>
            </name>
          </person-group>
          <article-title>Occurrence of breast carcinoma within a fibroadenoma: a review</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>1984</year>
          <volume>108</volume>
          <fpage>590</fpage>
          <lpage>594</lpage>
          <pub-id pub-id-type="pmid">6329129</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Diaz</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Palmer</surname>
              <given-names>JO</given-names>
            </name>
            <name>
              <surname>McDivitt</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>Carcinoma arising within fibroadenomas of the breast: a clinicopathologic study of 105 patients</article-title>
          <source>Am J Clin Pathol</source>
          <year>1991</year>
          <volume>95</volume>
          <fpage>614</fpage>
          <lpage>622</lpage>
          <pub-id pub-id-type="pmid">1850948</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
